MN HF1806

Health plans must cover at least two FDA-approved nonopioid prescription drugs (not Schedule I, II, or III controlled substances) for pain treatment and management

Health plans must cover at least three nonpharmacologic, nonoperative pain treatment modalities as alternatives to opioids

Health plans are prohibited from giving preferential coverage or access to opioids over nonopioid alternatives

Prior authorization and step therapy requirements for FDA-approved nonopioid pain drugs cannot be more restrictive than those applied to opioid drugs

Health plan companies must annually distribute educational materials about nonopioid pain treatment options to providers and enrollees, and post them on their websites; effective January 1, 2026